t
On 29 October 2026, MedPal AI plc announced that all resolutions were passed at its General Meeting. Following the vote, the company issued a total of 14,050,242 warrants to Clear Capital in relation to historical fundraises. The warrants comprise 5,000,000 at an 8p exercise price expiring 8 October 2030, 7,480,242 at 5.01p expiring 3 March 2029, and 1,570,000 at 2.5p expiring 26 March 2031.
| Date | 29 Oct 2026 |
| Time | 16:00:00 |
| Category | AGMs and other meetings |
| ID | 0602B |
29 October 2026
MedPal AI plc
("MedPal", the "Company" or the "Group")
Result of General Meeting
Issue of Warrants
Further to its announcement of 6 October 2026, MedPal AI plc (AIM: MPAL; FRA: Z1N), the AI-native digital health and pharmacy group, announces that announces that at the General Meeting of the Company held earlier today, all resolutions were duly passed. Accordingly, the Company has issued warrants to Clear Capital in relation to historical fundraises as shown below:
|
Number of Warrants |
Exercise Price |
Exercise Period |
|
5,000,000 |
8p |
the period ending on 8 October 2030 |
|
7,480,242 |
5.01p |
the period ending on 3 March 2029 |
|
1,570,000 |
2.5p |
the period ending on 26 March 2031 |
|
14,050,242 |
- |
|
For further information please contact:
Enquiries:
|
MedPal AI plc Jason Drummond, Chief Executive Officer |
Via Square1 Consulting |
|
Cairn Financial Advisers LLP (Nomad) Louise O'Driscoll / Jo Turner |
+44 (0) 20 7213 0880 |
|
Merlin Partners LLP (Broker)
|
+44 (0) 20 7839 3500 |
|
Clear Capital Markets Limited (Broker) Bob Roberts |
+44 (0) 20 3869 6080 |
|
Square1 Consulting - (Financial PR) David Bick |
+44 (0) 20 7929 5599 / +44 (0) 7831 381201 |
|
|
|
About MedPal AI plc
MedPal AI plc (AIM: MPAL; FRA: Z1N) is a vertically integrated, AI-native digital health and pharmacy group. The Group operates NHS Distance Selling Pharmacy hubs at Sarus Court, Runcorn and Swaffham, New Health (new.co.uk), a dedicated GLP-1 weight management clinic, a B2B care home pharmacy supply business, eMARx, the Group's electronic medication administration record software for care homes, and Juno, an agentic AI health companion built on Anthropic's Claude. MedPal's ambition is to build the UK's leading Health OS: a single platform connecting prescribing, dispensing, delivery, administration and AI-driven patient support. The Company's LEI is 984500EDP8B0A14CBA61.
END